StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$46.55+0.42 (+0.91%)

Close on Oct 19, 2026Market cap –P/E 24.0Yield 0.54%

Qiagen net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $424.88M, up 408.3% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $512.60M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$424.88M+408.3%
FY2024Dec 31, 2024$83.59M-75.5%
FY2023Dec 31, 2023$341.30M-19.4%
FY2022Dec 31, 2022$423.21M-17.4%
FY2021Dec 31, 2021$512.60M+42.7%
FY2020Dec 31, 2020$359.19M–
FY2019Dec 31, 2019-$41.46M-121.8%
FY2018Dec 31, 2018$190.38M+371.3%
FY2017Dec 31, 2017$40.39M-49.8%
FY2016Dec 31, 2016$80.40M-38.2%
FY2015Dec 31, 2015$130.15M+11.8%
FY2014Dec 31, 2014$116.37M+68.5%
FY2013Dec 31, 2013$69.07M-46.7%
FY2012Dec 31, 2012$129.51M+34.8%
FY2011Dec 31, 2011$96.04M-33.5%
FY2010Dec 31, 2010$144.31M+4.8%
FY2009Dec 31, 2009$137.77M+54.7%
FY2008Dec 31, 2008$89.03M–

More Qiagen figures

See a number that looks wrong?